<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-151524" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Blepharophimosis Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Neuhouser</surname>
            <given-names>Adam J.</given-names>
          </name>
          <aff>University of Minnesota</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zeppieri</surname>
            <given-names>Marco</given-names>
          </name>
          <aff>University Hospital of Udine, Italy</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Harrison</surname>
            <given-names>Andrew R.</given-names>
          </name>
          <aff>University of Minnesota</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Adam Neuhouser declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marco Zeppieri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Andrew Harrison declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-151524.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Blepharophimosis syndrome (BPES), which stands for blepharophimosis, ptosis, epicanthus inverse syndrome, is a rare genetic disorder primarily affecting eyelid development, resulting in a distinct facial appearance. The syndrome is characterized by:</p>
        <list list-type="bullet">
          <list-item>
            <p>Telecanthus: Increased distance between the inner corners of the eyes</p>
          </list-item>
          <list-item>
            <p>Ptosis: Drooping of the upper eyelid</p>
          </list-item>
          <list-item>
            <p>Epicanthus inversus: Upward fold of skin near the inner corner of the eye</p>
          </list-item>
        </list>
        <p>These features define BPES. The disruption of the development of the eyelid and associated tissues during embryogenesis is the cause of the structural abnormalities observed in BPES. The severity and subtype of BPES can vary, with some individuals experiencing significant visual impairment from ptosis, whereas others may have cosmetic concerns. The condition is restricted to the structural flaws that are present from birth and does not tend to spread. However, ptosis can lead to other issues, including amblyopia, if left untreated, which emphasizes the need for early detection and surgery. BPES is classified into 2 types.</p>
        <p>The 4 traditional clinical signs&#x02014;telecanthus, epicanthus inversus, ptosis, and blepharophimosis&#x02014;are present in every form. Type I is linked to early ovarian failure. Only the traditional facial traits define type II. If left untreated, these characteristics are linked to a high amblyopia risk. Early surgical intervention is necessary for both types to ensure normal development of eyesight. This activity reviews the clinical presentation, assessment, treatment, and management of BPES, emphasizing the role of an interprofessional healthcare team&#x02014;including endocrinologists, genetic counselors, and other medical professionals&#x02014;in optimizing patient care and outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Assess the typical physical examination findings associated with blepharophimosis syndrome.</p></list-item><list-item><p>Apply best practices for the treatment and management of blepharophimosis syndrome.</p></list-item><list-item><p>Implement recommended treatment considerations for patients with blepharophimosis syndrome who have additional systemic complications, including premature ovarian&#x000a0;insufficiency.</p></list-item><list-item><p>Collaborate with healthcare professionals and implement interprofessional team strategies to improve care, treatment outcomes, and management of patients with blepharophimosis syndrome.&#x000a0;</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=151524&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=151524">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-151524.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Blepharophimosis syndrome (BPES) is a relatively rare genetic condition that primarily affects eyelid formation and results&#x000a0;in a distinctive facial appearance present at birth.<xref ref-type="bibr" rid="article-151524.r1">[1]</xref> This condition was first described by Komoto in 1921.<xref ref-type="bibr" rid="article-151524.r2">[2]</xref>&#x000a0;The condition is characterized by the existence of a reduced horizontal opening of the eyelid (blepharophimosis), drooping of the upper eyelid (ptosis), increased distance between the inner corners of the eyes (telecanthus), and an upward fold of skin near the inner corner of the eye, where the medial eyelid skin fold appears more prominent in the lower eyelid, extending across the canthus and tapering into the upper eyelid (epicanthus inversus).<xref ref-type="bibr" rid="article-151524.r3">[3]</xref> These congenital features define the syndrome, hence the acronym BPES&#x000a0;(see<bold> Image.</bold><bold>&#x000a0;</bold>Male Child with Blepharophimosis Syndrome).<xref ref-type="bibr" rid="article-151524.r4">[4]</xref></p>
        <p>Blepharophimosis syndrome is an autosomal dominant disease affecting the eyelids and mid-face structures. These characteristics significantly impact the patient's vision and facial appearance. BPES can also be associated with additional systemic defects, specifically premature ovarian&#x000a0;insufficiency in females, resulting in BPES type I.<xref ref-type="bibr" rid="article-151524.r5">[5]</xref>&#x000a0;Most cases are caused by mutations in <italic toggle="yes">FOXL2</italic>&#x000a0;on chromosome 3q23.</p>
        <p>The structural defects observed in BPES are caused by the interruption of the development of the eyelid and related tissues during embryogenesis. The course of BPES is contingent upon the specific subtype and severity, resulting in varying outcomes. Some persons may encounter substantial visual impairment caused by ptosis, whereas others may be concerned with cosmetic issues. The condition has no propensity for dissemination but remains limited to the congenital structural defects. Nevertheless, if ptosis is not addressed, subsequent complications such as amblyopia may result, underscoring the importance of prompt detection and surgery.</p>
        <p>There are 2 main types of BPES. Each type harbors the 4 classic clinical signs&#x02014;blepharophimosis, ptosis, epicanthus inversus, and telecanthus. Type I is associated with premature ovarian insufficiency, whereas type II is characterized by the classic facial features alone. These features are associated with a high incidence of amblyopia if not correctly managed. Both types require surgical treatment early in life for normal vision development (see<bold> Image.</bold><bold>&#x000a0;</bold>Male Child After Surgery for Blepharophimosis Syndrome).</p>
      </sec>
      <sec id="article-151524.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>BPES is mainly caused by mutations in <italic toggle="yes">FOXL2</italic>, which is crucial for the development of eyelids and ovarian follicles. This gene encodes a forkhead family transcription factor that plays a vital role in controlling gene expression throughout embryonic development.<xref ref-type="bibr" rid="article-151524.r6">[6]</xref> Pathogenic mutations dsirupt the normal functioning of FOXL2, resulting in the observable characteristics of BPES.</p>
        <p>The genetic cause of BPES was discovered in 2001 through genetic sequencing of 7 families affected by BPES.<xref ref-type="bibr" rid="article-151524.r7">[7]</xref>&#x000a0;Pathogenic mutations in <italic toggle="yes">FOXL2</italic>&#x000a0;on chromosome 3q23 are responsible for BPES. <italic toggle="yes">FOXL2</italic> encodes a forkhead transcription factor of 376 amino acids, which contain a tract of 14 alanine residues. To date, over 100 unique <italic toggle="yes">FOXL2</italic> mutations have been identified in BPES families.<xref ref-type="bibr" rid="article-151524.r8">[8]</xref> The exact function of FOXL2 is unknown.<xref ref-type="bibr" rid="article-151524.r9">[9]</xref> Still, expression studies have shown that FOXL2 is expressed in the mesenchyme of developing fetal eyelids and the granulosa cells of fetal and adult ovaries.<xref ref-type="bibr" rid="article-151524.r7">[7]</xref></p>
        <p>The 2 types of BPES are phenotypically indistinguishable but can be determined through genetic testing. Mutations that truncate FOXL2 before the polyalanine tract result in type I BPES. Mutations that expand the polyalanine tract result in type II BPES.<xref ref-type="bibr" rid="article-151524.r10">[10]</xref>&#x000a0;BPES can be caused by various types of mutations including missense, nonsense, or frameshift mutations.<xref ref-type="bibr" rid="article-151524.r11">[11]</xref><xref ref-type="bibr" rid="article-151524.r12">[12]</xref> These mutations can result in a loss-of-function or dominant-negative effect.<xref ref-type="bibr" rid="article-151524.r13">[13]</xref> In individuals with type I BPES, the genetic abnormalities not only impact the formation of eyelids but also interfere with the functioning of the ovaries, resulting in premature ovarian insufficiency in affected females. Type II BPES is characterized by ocular manifestations without concurrent ovarian dysfunction.<xref ref-type="bibr" rid="article-151524.r14">[14]</xref></p>
      </sec>
      <sec id="article-151524.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>BPES is a rare disorder, occurring in approximately 1 of 50,000 newborns.<xref ref-type="bibr" rid="article-151524.r15">[15]</xref>&#x000a0;Although type I BPES affects both males and females, the specific risk of early ovarian insufficiency is exclusive to females. The syndrome has been observed in several ethnic groups globally, without any notable geographical or ethnic inclination observed. Most cases of BPES are familial&#x000a0;via an autosomal dominant pattern. However, spontaneous mutations may occur. Within&#x000a0;affected families, BPES generally shows complete penetrance but exhibits varying expressivity, implying that the degree of eyelid abnormalities and related symptoms can greatly differ, even among individuals within the same family.</p>
        <p>Up to 75% of affected individuals have a <italic toggle="yes">FOXL2</italic> mutation.<xref ref-type="bibr" rid="article-151524.r15">[15]</xref>&#x000a0;Approximately 64% of cases occur in women.<xref ref-type="bibr" rid="article-151524.r16">[16]</xref>&#x000a0;Type I has 100% penetrance and is transmitted primarily through males due to females developing premature ovarian&#x000a0;insufficiency and reduced fertility. Type II has 96.5% penetrance and is transmitted through males and females.<xref ref-type="bibr" rid="article-151524.r17">[17]</xref><xref ref-type="bibr" rid="article-151524.r16">[16]</xref> The incidence of strabismus in BPES is 20 to 27%.<xref ref-type="bibr" rid="article-151524.r18">[18]</xref>&#x000a0;Development of amblyopia from ptosis or strabismus is between 39% and 56%.<xref ref-type="bibr" rid="article-151524.r17">[17]</xref>&#x000a0;Refractive error is common and as high as 94%, with simple hyperopia being the most common etiology.<xref ref-type="bibr" rid="article-151524.r15">[15]</xref></p>
      </sec>
      <sec id="article-151524.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The underlying mechanism of BPES revolves around the interference with typical eyelid and face formation caused by abnormalities in <italic toggle="yes">FOXL2</italic>. The eyelid abnormalities, such as blepharophimosis, ptosis, and epicanthus inversus, occur due to the hindered differentiation and migration of the mesenchymal tissues that shape the eyelids during embryonic development. The most frequently observed characteristics are constricted palpebral fissures, drooping eyelids, and telecanthus. Type I BPES is characterized by a <italic toggle="yes">FOXL2&#x000a0;</italic>mutation, which causes ovarian dysfunction and disrupts the process of folliculogenesis, leading to early ovarian insufficiency.</p>
        <p>Eyelid morphogenesis is a complex process involving the coordinated movement of neural crest-derived periocular mesenchymal cells during embryonic development. These cells form eyelid structures, including the levator palpebrae superioris, smooth muscle, and tarsus.<xref ref-type="bibr" rid="article-151524.r19">[19]</xref>&#x000a0;</p>
        <p>In congenital ptosis, the levator palpebrae superioris muscle is maldeveloped, resulting in a droopy upper eyelid. Genes associated with congenital ptosis include <italic toggle="yes">ZFH4</italic> and <italic toggle="yes">FOXL2</italic>. Mutations in <italic toggle="yes">FOXL2</italic> disrupt actin gene expression in the smooth muscle cells of periocular mesenchyma. This disruption results in severe hypoplasia of the levator palpebrae superioris and other craniofacial defects, causing blepharophimosis, ptosis, and epicanthus inversus.<xref ref-type="bibr" rid="article-151524.r19">[19]</xref><xref ref-type="bibr" rid="article-151524.r20">[20]</xref></p>
        <p>The <italic toggle="yes">FOXL2</italic> transcription factor is crucial in sexual development and ovarian function. The expression of <italic toggle="yes">FOXL2</italic> is the highest in granulosa cells of the ovary, and it plays a vital role in folliculogenesis, hormone signaling, cell regulation, proliferation, and apoptosis. In the absence of FOXL2, primary follicle formation in the ovaries is disrupted, and the number of follicles recruited during fetal ovarian development is depleted. The decreased number of follicles formed during ovarian development causes premature ovarian insufficiency and sequelae of reduced estrogen.<xref ref-type="bibr" rid="article-151524.r9">[9]</xref><xref ref-type="bibr" rid="article-151524.r21">[21]</xref></p>
      </sec>
      <sec id="article-151524.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>In cases of BPES, histopathological analysis of tissue indicates the presence of undeveloped or dysplastic levator palpebrae muscles, which are responsible for raising the eyelids.<xref ref-type="bibr" rid="article-151524.r22">[22]</xref> Abnormalities may also be observed in the connective tissue components of the eyelids, such as the tarsus and orbicularis oculi muscle.<xref ref-type="bibr" rid="article-151524.r23">[23]</xref> In instances involving concurrent premature ovarian insufficiency, an examination of the ovaries by biopsy may uncover a diminished quantity of follicles and other indications that are in line with ovarian dysgenesis.<xref ref-type="bibr" rid="article-151524.r24">[24]</xref> Nevertheless, histopathology is not commonly employed for diagnosing BPES, as the primary methods used are clinical and genetic.</p>
      </sec>
      <sec id="article-151524.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The evaluation of a patient with BPES typically starts with the observations of ocular abnormalities shortly after birth. There may be a hereditary pattern of comparable facial characteristics or a history of early menopause in female relatives. The physical examination reveals the characteristic manifestations of the syndrome, including blepharophimosis (narrowed eyelid fissures), ptosis (drooping of the upper eyelids), telecanthus (increased distance between the inner corners of the eyes), and epicanthus inversus (an upward fold of skin near the inner corner of the eye). These findings are typically bilateral and symmetrical.</p>
        <p>Females with type I BPES may show signs of premature ovarian insufficiency, such as irregular menstrual periods or secondary amenorrhea, during adolescence or early adulthood. The degree of ptosis might vary, with certain patients encountering substantial visual blockage requiring prompt surgical intervention.</p>
        <p>The diagnosis of BPES is mainly clinical (see<bold> Image.</bold><bold>&#x000a0;</bold>Male Child with Blepharophimosis Syndrome). Physical examination findings include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Blepharophimosis:&#x000a0;A horizontal shortening of the palpebral fissure. The average horizontal palpebral fissure measures 25&#x000a0;to 30 mm, but in BPES,&#x000a0;it measures 20&#x000a0;to 22 mm.<xref ref-type="bibr" rid="article-151524.r25">[25]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Ptosis: Upper eyelid droopiness develops from bilateral dysplasia of the levator palpebral superioris muscle, resulting in poor levator function and bilateral ptosis.<xref ref-type="bibr" rid="article-151524.r26">[26]</xref><xref ref-type="bibr" rid="article-151524.r27">[27]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Epicanthus inverus: A skin fold arising from the medial lower eyelid and running inward and upward to the upper eyelid. This feature is always bilateral; the caruncle and plica semilunaris beneath have a hypoplastic appearance.<xref ref-type="bibr" rid="article-151524.r28">[28]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Telecanthus:&#x000a0;The bony walls of the orbit are unaffected in BPES. The medial canthal tendons are elongated, which causes a widened intercanthal distance with normal interpupillary distance.<xref ref-type="bibr" rid="article-151524.r29">[29]</xref></p>
          </list-item>
        </list>
        <p>There are 2 clinical types of BPES.</p>
        <list list-type="bullet">
          <list-item>
            <p>Type I BPES is characterized by blepharophimosis, ptosis, epicanthus inversus, telecanthus, and premature ovarian insufficiency.</p>
          </list-item>
          <list-item>
            <p>Type II BPES is characterized by the same classic 4 findings without premature ovarian insufficiency.</p>
          </list-item>
        </list>
        <p>Numerous other coexisting&#x000a0;malformations and compensatory responses have been reported. Craniofacial malformations include thin and short upper eyelid skin with a margin that has an S-shape, whereas the lower margin has a downward concavity, with or without slight ectropion.<xref ref-type="bibr" rid="article-151524.r30">[30]</xref><xref ref-type="bibr" rid="article-151524.r31">[31]</xref>&#x000a0;</p>
        <p>Abnormalities of the lacrimal drainage apparatus include lateral displacement of the lower punctum, canaliculi stenosis, and elongation of the horizontal canaliculi.<xref ref-type="bibr" rid="article-151524.r32">[32]</xref><xref ref-type="bibr" rid="article-151524.r33">[33]</xref>&#x000a0;Other ophthalmic manifestations include strabismus, microphthalmos, and optic disc coloboma.<xref ref-type="bibr" rid="article-151524.r34">[34]</xref>&#x000a0;Facial abnormalities include wide and flattened nasal bridges and anteverted ears.<xref ref-type="bibr" rid="article-151524.r16">[16]</xref>&#x000a0;</p>
        <p>Individuals compensate for ptosis by adopting a chin-up head position and constantly contracting their frontalis muscles. The eyebrows can become more prominent and arched, giving patients a continually surprised look.<xref ref-type="bibr" rid="article-151524.r2">[2]</xref></p>
      </sec>
      <sec id="article-151524.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The assessment of BPES involves a combination of clinical examination and genetic testing. Diagnosis is typically made by observing distinctive facial characteristics and confirmed through genetic testing that identifies pathogenic mutations in <italic toggle="yes">FOXL2</italic>.<xref ref-type="bibr" rid="article-151524.r35">[35]</xref>
<italic toggle="yes">FOXL2</italic> sequencing is considered the most reliable method for diagnosis.<xref ref-type="bibr" rid="article-151524.r36">[36]</xref> Procedures such as chromosomal microarray analysis or karyotyping might be used to detect significant deletions or chromosomal rearrangements affecting 3q23.<xref ref-type="bibr" rid="article-151524.r37">[37]</xref></p>
        <p>In addition to genetic testing, a thorough ophthalmologic evaluation is essential,&#x000a0;involving the measurement of palpebral fissure length, evaluation of ptosis severity, and examination of levator palpebrae muscle functionality. Visual acuity should also be evaluated to identify any associated conditions, such as amblyopia. Endocrine assessment may be required in females, especially those with type I BPES, to determine ovarian function.<xref ref-type="bibr" rid="article-151524.r38">[38]</xref></p>
        <p>Individuals&#x000a0;with the characteristic features of BPES can undergo gene-targeted testing to detect mutations in <italic toggle="yes">FOXL2</italic>.<xref ref-type="bibr" rid="article-151524.r39">[39]</xref> If no variant is detected, comprehensive genomic testing can be conducted to detect deletions or duplications in the&#x000a0;<italic toggle="yes">FOXL2&#x000a0;</italic>region. In some cases, cytogenetic testing is completed to further evaluate for balanced translocations or other interruptions of the <italic toggle="yes">FOXL2</italic> region.<xref ref-type="bibr" rid="article-151524.r8">[8]</xref><xref ref-type="bibr" rid="article-151524.r40">[40]</xref></p>
        <p>Female individuals with type I BPES develop primary ovarian insufficiency, manifesting as pubertal delay, primary amenorrhea, secondary amenorrhea, or oligomenorrhea. Endocrinologic laboratory testing can aid in diagnosis, with elevated levels of follicle-stimulating and luteinizing hormones and decreased serum concentrations of estrogen and progesterone. Transvaginal ultrasound with antral follicular count can assess ovarian reserve and aid discussions regarding poor fertility.<xref ref-type="bibr" rid="article-151524.r41">[41]</xref></p>
      </sec>
      <sec id="article-151524.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management of BPES involves multiple disciplines, including ophthalmology, genetics, and, in the case of type I BPES, endocrinology. The main objectives of treatment are to enhance visual function and address aesthetic considerations.&#x000a0;Treatment goals include surgical eyelid repair to promote normal visual development, improve cosmesis, alleviate neck strain from chin-up posture, and address primary ovarian insufficiency and infertility in females with type I BPES.&#x000a0;Initial management involves a pediatric ophthalmologist assessing for amblyopia, strabismus, and refractive error. Referral to an oculoplastic surgeon should be made to evaluate the degree of ptosis, blepharophimosis, and epicanthus inversus (see<bold> Image.</bold><bold>&#x000a0;</bold>Male Child After Surgery for Blepharophimosis Syndrome).<xref ref-type="bibr" rid="article-151524.r42">[42]</xref></p>
        <p>Surgical correction is the primary treatment for eyelid abnormalities. Ptosis correction is frequently necessary to prevent or treat amblyopia. Frontalis sling surgery, a procedure that uses a suspensory device to raise the eyelid, is commonly employed. Medial canthoplasty is a surgical procedure that can repair telecanthus by repositioning the inner corners of the eyelids to a more typical position. Traditionally, eyelid correction was performed as a 2-stage surgery at 3 to&#x000a0;5 years of age. A medial canthoplasty using&#x000a0;the Mustarde technique or double-opposing z-plasty to repair epicanthus inversus and telecanthus is followed by frontalis suspension for ptosis repair 6 to 12 months later. Performing ptosis correction and medial canthoplasty simultaneously could lead to tension between tightened vertical and horizontal tissues, potentially reducing the effectiveness of the procedures if done separately.<xref ref-type="bibr" rid="article-151524.r42">[42]</xref><xref ref-type="bibr" rid="article-151524.r43">[43]</xref></p>
        <p>Some surgeons argue that medial canthus reconstruction can worsen ptosis and should be addressed first. Other surgeons recommend repairing ptosis first due to the high incidence of amblyopia and then performing medial canthus repair at a later age when the face has grown. Recent reports have described successful outcomes with single-stage surgery combining medial canthoplasty and ptosis repair for a select group of individuals.&#x000a0;Additional studies are required to assess the outcomes of single-stage versus two-stage repair.<xref ref-type="bibr" rid="article-151524.r44">[44]</xref></p>
        <p>In general, the following surgical recommendations are made:</p>
        <list list-type="bullet">
          <list-item>
            <p>If the central visual axis is unobstructed, surgical repair can wait until 3&#x000a0;to 5 years.</p>
          </list-item>
          <list-item>
            <p>If the central visual axis is obscured, but the vertical interpalpebral fissure height is more than 2 mm, either single-stage or two-stage repair is associated with satisfactory outcomes.<xref ref-type="bibr" rid="article-151524.r45">[45]</xref></p>
          </list-item>
          <list-item>
            <p>If the central visual axis is obscured, and the vertical interpalpebral fissure height is less than 2 mm, a two-stage repair should be pursued as early as possible, involving ptosis repair first to prevent amblyopia, followed by medial canthoplasty.<xref ref-type="bibr" rid="article-151524.r17">[17]</xref></p>
          </list-item>
        </list>
        <p>Females who inherit BPES&#x000a0;from the paternal parent are more likely to have type I disease and should be referred to a clinical geneticist to discuss the nature of the disease, its mode of inheritance, and the fertility implications of the genetic disorder.<xref ref-type="bibr" rid="article-151524.r46">[46]</xref> Women should be informed of the risk of premature ovarian&#x000a0;insufficiency and referred to a pediatric or reproductive endocrinologist and gynecologist to monitor ovarian status. Hormone replacement therapy is recommended to address early ovarian insufficiency and to prevent the long-term consequences of estrogen deprivation, such as osteoporosis and cardiovascular disease. Young women may consider fertility preservation alternatives, such as oocyte or embryo cryopreservation, before the decrease of ovarian function.<xref ref-type="bibr" rid="article-151524.r47">[47]</xref><xref ref-type="bibr" rid="article-151524.r48">[48]</xref> The American Society for Reproductive Medicine and the International Menopause Society recommend estrogen replacement therapy for women with primary ovarian insufficiency.<xref ref-type="bibr" rid="article-151524.r49">[49]</xref> Hormone replacement therapy under the guidance of an endocrinologist and gynecologist is reasonable for maintaining normal bone mineral density. The options for women who wish to pursue parenthood include adoption, foster parenthood, embryo donation, egg donation, and cryopreservation.<xref ref-type="bibr" rid="article-151524.r50">[50]</xref><xref ref-type="bibr" rid="article-151524.r46">[46]</xref></p>
        <p>Genetic counseling is a process that involves providing individuals and families with information about genetic conditions, inheritance patterns, and the risks of passing on genetic disorders. The goal is to assist individuals in making informed decisions about family planning.<xref ref-type="bibr" rid="article-151524.r51">[51]</xref> Affected families are advised to undergo genetic counseling to discuss inheritance patterns, the likelihood of passing on the condition to their children, and available reproductive choices. Families with known <italic toggle="yes">FOXL2</italic> mutations can access prenatal genetic testing and preimplantation genetic diagnosis.<xref ref-type="bibr" rid="article-151524.r52">[52]</xref></p>
      </sec>
      <sec id="article-151524.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Most patients with BPES have a clear family history, but de novo mutations are possible.<xref ref-type="bibr" rid="article-151524.r53">[53]</xref>&#x000a0;If eyelid findings are present without a clear family history, it is important to consider other conditions that include ptosis and blepharophimosis as major characteristic features&#x02014;NR2F2-associated 46, XX sex reversal 5, the Say-Barber-Biesecker variant of Ohdo syndrome, congenital ptosis, ptosis with external ophthalmoplegia, Noonan syndrome, Marden-Walker syndrome, Schwartz Jampel syndrome, Waardenburg syndrome, Williams syndrome, trisomy 18, cerebro-oculo-facial-digital syndrome, Dubowitz syndrome, and Smith-Lemli-Opitz syndrome.<xref ref-type="bibr" rid="article-151524.r54">[54]</xref><xref ref-type="bibr" rid="article-151524.r55">[55]</xref></p>
        <p>Conditions such as congenital ptosis&#x000a0;<xref ref-type="bibr" rid="article-151524.r56">[56]</xref> caused by isolated levator muscle failure must be distinguished from BPES, in which ptosis is a component of a more comprehensive syndrome. Waardenburg syndrome&#x000a0;<xref ref-type="bibr" rid="article-151524.r57">[57]</xref> is defined by the presence of dystopia canthorum (abnormally wide-set eyes), which can sometimes be mistaken for BPES. Nevertheless, Waardenburg syndrome encompasses hearing impairment and abnormalities in pigmentation, whereas these characteristics are not present in BPES. Individuals with Noonan syndrome&#x000a0;<xref ref-type="bibr" rid="article-151524.r58">[58]</xref> may exhibit ptosis (drooping of the upper eyelid) and hypertelorism (increased distance between the eyes), along with other characteristics such as below average&#x000a0;height, congenital cardiac abnormalities, and delays in development. Apert syndrome&#x000a0;<xref ref-type="bibr" rid="article-151524.r59">[59]</xref> can be distinguished from BPES by the presence of syndactyly (fusion of fingers and toes), severe skull malformations, and craniofacial anomalies.</p>
      </sec>
      <sec id="article-151524.s11" sec-type="Staging">
        <title>Staging</title>
        <p>BPES does not adhere to a conventional stage scheme, as shown in oncological conditions. Nevertheless, it is possible to categorize it according to the kind (type I or type II) and the severity of symptoms, specifically in terms of their effect on vision and ovarian function. The classification assists in directing the care strategy, especially in females, where timely recognition of&#x000a0;type I BPES is crucial for treating premature ovarian insufficiency.<xref ref-type="bibr" rid="article-151524.r60">[60]</xref></p>
      </sec>
      <sec id="article-151524.s12" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The outlook for individuals with BPES is typically favorable with proper care. Timely surgical intervention for ptosis can effectively avoid the development of amblyopia and enhance visual results (see<bold> Image.</bold><bold>&#x000a0;</bold>Male Child After Surgery for Blepharophimosis Syndrome). Cosmetic surgery has the potential to significantly improve the physical appearance and psychological well-being of individuals&#x000a0;who undergo it.<xref ref-type="bibr" rid="article-151524.r61">[61]</xref> The reproductive prognosis&#x000a0;of females with type I BPES depends on the timing and severity of ovarian insufficiency. Early identification and intervention can alleviate certain detrimental consequences linked to early ovarian insufficiency. Patients require a multidisciplinary approach and coordination of care across many specialties. The prognosis is excellent when medical and surgical management is addressed early in life. Depending on the severity of the disorder, surgical treatment can require multiple stages, but outcomes are very successful. Patients with BPES have an average lifespan.</p>
      </sec>
      <sec id="article-151524.s13" sec-type="Complications">
        <title>Complications</title>
        <p>The primary complications of BPES result from untreated ptosis, which can cause amblyopia by blocking the visual axis during crucial stages of visual development. Possible surgical consequences may involve the occurrence of either under- or overcorrection of the condition. Ptosis, asymmetry, and scarring are present. Type I BPES is associated with problems such as infertility, osteoporosis, and cardiovascular disease, all&#x000a0;resulting from prolonged estrogen deficiency due to premature ovarian insufficiency. Females with typical facial features and concomitant infertility may also experience psychological challenges, such as low self-esteem and social difficulties. Complications can occur after surgical repair. Early popular techniques, such as the Mustarde technique and z-epicanthoplasty, had major incidences of severe scarring. Other techniques, such as the Y-to-V technique and medial epicanthoplasty with skin redraping, have been developed to improve cosmetic outcomes.<xref ref-type="bibr" rid="article-151524.r62">[62]</xref></p>
        <p>Many organic and inorganic materials are used for frontalis sling suspension to treat congenital ptosis surgically. Alloplastic materials include braided polyester sutures, polypropylene sutures, expanded polytetrafluorethylene, and silastic bands. Placing foreign material in the tissue can result in granulomatous formation, infection, or extrusion.<xref ref-type="bibr" rid="article-151524.r63">[63]</xref></p>
        <p>Homografts, such as autogenous fascia lata, are associated with longer recovery time and a second potential site of infection. Overcorrection of congenital ptosis can result in lagophthalmos and cause corneal complications.</p>
      </sec>
      <sec id="article-151524.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Education for individuals and families affected by BPES should prioritize the significance of early identification and intervention to mitigate visual problems. Educating parents about the signs of amblyopia and the importance of regular ophthalmologic monitoring is essential. For females with&#x000a0;type I BPES, it is crucial to provide early information to about the risks of premature ovarian insufficiency and the available alternatives for fertility preservation. Genetic counseling is essential for delivering precise information regarding the pattern of inheritance, potential dangers to future offspring, and the range of available reproductive options.</p>
        <p>Families must understand the need for lifelong monitoring of vision into adulthood. Surgery is almost always necessary early in life to prevent amblyopia, and it may be required again later in adulthood for cosmetic reconstruction if desired.</p>
        <p>Families and patients should know that multiple methods exist to lift the eyelid and repair ptosis. The operation should be personalized to the patient's needs. When considering any procedure, a do-nothing option should be explained to the family and patient. Adolescence can be a challenging time for female patients, and support from a multidisciplinary team of healthcare providers&#x000a0;is necessary. Genetic testing also involves different approaches. Females should discuss infertility and family planning with a genetic counselor.</p>
      </sec>
      <sec id="article-151524.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>BPES should be considered a possible diagnosis in infants who display the distinctive combination of blepharophimosis, ptosis, telecanthus, and epicanthus inversus. The diagnosis can be confirmed through genetic testing for <italic toggle="yes">FOXL2</italic> mutations. Prompt surgical surgery for ptosis is essential to prevent the development of amblyopia. Regular ophthalmologic surveillance is essential to assess the progress of visual development and determine whether further surgical interventions are required. Genetic counseling and reproductive alternatives, such as prenatal diagnosis and preimplantation genetic diagnosis, should be considered in families with a hereditary predisposition to BPES.</p>
      </sec>
      <sec id="article-151524.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Management of BPES is complex and requires a multidisciplinary approach, including a pediatric ophthalmologist, oculoplastic surgeon, pediatrician, endocrinologist, gynecologist, nurses, and genetic counselor. Ophthalmologists play a critical role in educating fellow clinicians and healthcare professionals about the risk of amblyopia and its visual implications if unrecognized.</p>
        <p>Genetic information is complex, and genetic counselors are essential in educating families and patients on test results. The decision to pursue genetic testing is very personal, particularly for female patients. FOXL2 gene mutation analysis is primarily used to identify future fertility status. Genetic counselors can lead one-on-one counseling to families regarding unexpected test results and discussions regarding reproductive choices. The Clinical Genetics Society recommends postponing genetic testing for disorders with purely reproductive implications until the individual has reached an age or level of maturity where they can fully understand the impact of the test and make an informed decision about whether to proceed with testing.<xref ref-type="bibr" rid="article-151524.r64">[64]</xref></p>
        <p>Endocrinologists and gynecologists are critical in the&#x000a0;interprofessional approach to treating these patients. Individuals with type I BPES should be referred to an endocrinologist to address ovarian insufficiency and administer suitable hormonal therapy. Regular interprofessional meetings can facilitate the coordination of care and enhance patient outcomes. Low estrogen levels at a young age increase the risk of osteoporosis, heart disease, and depression. Women with premature ovarian failure cannot get pregnant naturally but can carry a pregnancy with in vitro fertilization with donor oocytes. Patients should be referred to a gynecologist or infertility specialist to discuss reproductive treatments. Ensuring patients understand reproductive biology and therapeutic options can help them cope with this emotionally distressing condition.</p>
        <p>Involving patients and their families in decision-making is crucial, particularly when it comes to surgical alternatives and genetic counseling. Providing the family with information about the ailment and treatment alternatives facilitates the ability to make well-informed decisions and improves compliance with treatment regimens.</p>
        <p>BPES raises ethical concerns related to fertility preservation and the possibility of doing preimplantation genetic diagnosis in families with identified FOXL2 mutations. These discussions should be approached with sensitivity while respecting the patient's right to make decisions about their health and considering their cultural views.</p>
        <p>By providing comprehensive care that addresses the physical and psychological elements of BPES, healthcare professionals can significantly enhance the quality of life for individuals affected by this condition. To uphold a superior level of care, it is advisable to engage in regular training and stay updated on the most recent guidelines and surgical methods.</p>
      </sec>
      <sec id="article-151524.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=151524&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=151524">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/blepharophimosis-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=151524">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/151524/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=151524">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-151524.s18">
        <fig id="article-151524.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Male Child with Blepharophimosis Syndrome. The image shows the classic findings of blepharophimosis, ptosis, and epicanthus inverus in each eye, and telecanthus. Contributed by A Harrison, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="image" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-151524.s19">
        <fig id="article-151524.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Male Child After Surgery for Blepharophimosis Syndrome. The image shows a male patient 3 weeks after surgical repair of blepharophimosis syndrome. Ptosis repair is performed by frontalis suspension, and telecanthus repair is performed by transnasal wiring. Contributed by A Harrison, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="image__x1x" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-151524.s20">
        <title>References</title>
        <ref id="article-151524.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>M&#x000e9;j&#x000e9;case</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nigam</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moosajee</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bladen</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>The Genetic and Clinical Features of <italic>FOXL2</italic>-Related Blepharophimosis, Ptosis and Epicanthus Inversus Syndrome.</article-title>
            <source>Genes (Basel)</source>
            <year>2021</year>
            <month>Mar</month>
            <day>04</day>
            <volume>12</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">33806295</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Allen</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Rubin</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES): clinical manifestation and treatment.</article-title>
            <source>Int Ophthalmol Clin</source>
            <year>2008</year>
            <season>Spring</season>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>15</fpage>
            <page-range>15-23</page-range>
            <pub-id pub-id-type="pmid">18427257</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gupta</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Razi</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Blepharophimosis Ptosis Epicanthus Inversus Syndrome (BPES) Type 1 in an Indian Family.</article-title>
            <source>J ASEAN Fed Endocr Soc</source>
            <year>2017</year>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>68</fpage>
            <page-range>68-71</page-range>
            <pub-id pub-id-type="pmid">33442089</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r4">
          <label>4</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Verdin</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matton</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>De Baere</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <chapter-title>Blepharophimosis, Ptosis, and Epicanthus Inversus Syndrome</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>2004</year>
            <month>7</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">20301614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Shu</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Confrontment and solution to gonadotropin resistance and low oocyte retrieval in in vitro fertilization for type I BPES: a case series with review of literature.</article-title>
            <source>J Ovarian Res</source>
            <year>2021</year>
            <month>Oct</month>
            <day>28</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>143</fpage>
            <pub-id pub-id-type="pmid">34711234</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ge</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhuang</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A Novel Forkhead Box L2 Missense Mutation, c.1068G&#x0003e;C, in a Chinese Family With Blepharophimosis/Ptosis/ Epicanthus Inversus Syndrome.</article-title>
            <source>J Craniofac Surg</source>
            <year>2022</year>
            <month>May</month>
            <day>01</day>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>e238</fpage>
            <page-range>e238-e240</page-range>
            <pub-id pub-id-type="pmid">34374675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crisponi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Deiana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Loi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chiappe</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Uda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Amati</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bisceglia</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zelante</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nagaraja</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Porcu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ristaldi</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Marzella</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rocchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nicolino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lienhardt-Roussie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nivelon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Verloes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schlessinger</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gasparini</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bonneau</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pilia</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome.</article-title>
            <source>Nat Genet</source>
            <year>2001</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>159</fpage>
            <page-range>159-66</page-range>
            <pub-id pub-id-type="pmid">11175783</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beysen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>De Paepe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>De Baere</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>FOXL2 mutations and genomic rearrangements in BPES.</article-title>
            <source>Hum Mutat</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>158</fpage>
            <page-range>158-69</page-range>
            <pub-id pub-id-type="pmid">18726931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tucker</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>The Genetics and Biology of FOXL2.</article-title>
            <source>Sex Dev</source>
            <year>2022</year>
            <volume>16</volume>
            <issue>2-3</issue>
            <fpage>184</fpage>
            <page-range>184-193</page-range>
            <pub-id pub-id-type="pmid">34727551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Baere</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Beysen</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Oley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lorenz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cocquet</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>De Sutter</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Devriendt</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dixon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fellous</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fryns</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Garza</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jonsrud</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Koivisto</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Leroy</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Meire</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Plomp</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Van Maldergem</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>De Paepe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Veitia</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Messiaen</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation.</article-title>
            <source>Am J Hum Genet</source>
            <year>2003</year>
            <month>Feb</month>
            <volume>72</volume>
            <issue>2</issue>
            <fpage>478</fpage>
            <page-range>478-87</page-range>
            <pub-id pub-id-type="pmid">12529855</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>ZB</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>ZJ</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>XR</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pan</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Expanded phenotypic spectrum of FOXL2 Variant c.672_701dup revealed by whole-exome sequencing in a rare blepharophimosis, ptosis, and epicanthus inversus syndrome family.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2023</year>
            <month>Nov</month>
            <day>07</day>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>446</fpage>
            <pub-id pub-id-type="pmid">37932670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chai</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Deletion of cis-regulatory Element in FOXL2 Promoter in a Chinese Family of Type II Blepharophimosis-ptosis-epicanthus Inversus Syndrome with Polydactyly.</article-title>
            <source>J Craniofac Surg</source>
            <string-date>2024 Jan-Feb 01</string-date>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>e52</fpage>
            <page-range>e52-e56</page-range>
            <pub-id pub-id-type="pmid">37938073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fuller</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Alexiadis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>FOXL2<sup>C134W</sup> : much ado about something!<sup>&#x02020;</sup>.</article-title>
            <source>J Pathol</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>256</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-3</page-range>
            <pub-id pub-id-type="pmid">34687235</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fran&#x000e7;a</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Mendonca</surname>
                <given-names>BB</given-names>
              </name>
            </person-group>
            <article-title>Genetics of ovarian insufficiency and defects of folliculogenesis.</article-title>
            <source>Best Pract Res Clin Endocrinol Metab</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>36</volume>
            <issue>1</issue>
            <fpage>101594</fpage>
            <pub-id pub-id-type="pmid">34794894</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chawla</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bhadange</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Dada</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bajaj</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Pushker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Chandra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ghose</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Clinical, radiologic, and genetic features in blepharophimosis, ptosis, and epicanthus inversus syndrome in the Indian population.</article-title>
            <source>Invest Ophthalmol Vis Sci</source>
            <year>2013</year>
            <month>Apr</month>
            <day>26</day>
            <volume>54</volume>
            <issue>4</issue>
            <fpage>2985</fpage>
            <page-range>2985-91</page-range>
            <pub-id pub-id-type="pmid">23513057</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krastinova</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jasinski</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Orbitoblepharophimosis syndrome: a 16-year perspective.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>111</volume>
            <issue>3</issue>
            <fpage>987</fpage>
            <page-range>987-99</page-range>
            <pub-id pub-id-type="pmid">12621168</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beckingsale</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Sullivan</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Oley</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Blepharophimosis: a recommendation for early surgery in patients with severe ptosis.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2003</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>138</fpage>
            <page-range>138-42</page-range>
            <pub-id pub-id-type="pmid">12648048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dawson</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Hardy</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Collin</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>The incidence of strabismus and refractive error in patients with blepharophimosis, ptosis and epicanthus inversus syndrome (BPES).</article-title>
            <source>Strabismus</source>
            <year>2003</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>173</fpage>
            <page-range>173-7</page-range>
            <pub-id pub-id-type="pmid">14710475</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>Wakayama Symposium: Notch-FoxL2-&#x003b1;-SMA axis in eyelid levator muscle development and congenital blepharophimosis.</article-title>
            <source>Ocul Surf</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>221</fpage>
            <page-range>221-3</page-range>
            <pub-id pub-id-type="pmid">23084143</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heude</surname>
                <given-names>&#x000c9;</given-names>
              </name>
              <name>
                <surname>Bellessort</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fontaine</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hamazaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Treier</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Treier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Levi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Narboux-N&#x000ea;me</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Etiology of craniofacial malformations in mouse models of blepharophimosis, ptosis and epicanthus inversus syndrome.</article-title>
            <source>Hum Mol Genet</source>
            <year>2015</year>
            <month>Mar</month>
            <day>15</day>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>1670</fpage>
            <page-range>1670-81</page-range>
            <pub-id pub-id-type="pmid">25416281</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harris</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Chand</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Winship</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Gersak</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Aittom&#x000e4;ki</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shelling</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Identification of novel mutations in FOXL2 associated with premature ovarian failure.</article-title>
            <source>Mol Hum Reprod</source>
            <year>2002</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>8</issue>
            <fpage>729</fpage>
            <page-range>729-33</page-range>
            <pub-id pub-id-type="pmid">12149404</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>XW</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Gong</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>XR</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>GX</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>YQ</given-names>
              </name>
            </person-group>
            <article-title>Novel FOXL2 mutations cause blepharophimosis-ptosis-epicanthus inversus syndrome with premature ovarian insufficiency.</article-title>
            <source>Mol Genet Genomic Med</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>261</fpage>
            <page-range>261-267</page-range>
            <pub-id pub-id-type="pmid">29378385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xue</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Hejtmancik</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Novel FOXL2 mutations in two Chinese families with blepharophimosis-ptosis-epicanthus inversus syndrome.</article-title>
            <source>BMC Med Genet</source>
            <year>2015</year>
            <month>Sep</month>
            <day>01</day>
            <volume>16</volume>
            <fpage>73</fpage>
            <pub-id pub-id-type="pmid">26323275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kee</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>FOXL2 and NR5A1 induce human fibroblasts into steroidogenic ovarian granulosa-like cells.</article-title>
            <source>Cell Prolif</source>
            <year>2024</year>
            <month>May</month>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>e13589</fpage>
            <pub-id pub-id-type="pmid">38192172</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>JOHNSON</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>SURGICAL REPAIR OF THE SYNDROME OF EPICANTHUS INVERSUS, BLEPHAROPHIMOSIS AND PTOSIS.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1964</year>
            <month>Apr</month>
            <volume>71</volume>
            <fpage>510</fpage>
            <page-range>510-6</page-range>
            <pub-id pub-id-type="pmid">14109036</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Beaconsfield</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Collin</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Visual development in the blepharophimosis syndrome.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1991</year>
            <month>Dec</month>
            <volume>75</volume>
            <issue>12</issue>
            <fpage>746</fpage>
            <page-range>746-8</page-range>
            <pub-id pub-id-type="pmid">1768667</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>KLEIN</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Hereditary bilateral ptosis and blepharophimosis associated with other developmental abnormalities of the outer eye.</article-title>
            <source>Proc R Soc Med</source>
            <year>1950</year>
            <month>Dec</month>
            <volume>43</volume>
            <issue>12</issue>
            <fpage>1025</fpage>
            <page-range>1025-6</page-range>
            <pub-id pub-id-type="pmid">14808191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kohn</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>PE</given-names>
              </name>
            </person-group>
            <article-title>Blepharoptosis, blepharophimosis, epicanthus inversus, and telecanthus--a syndrome with no name.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1971</year>
            <month>Sep</month>
            <volume>72</volume>
            <issue>3</issue>
            <fpage>625</fpage>
            <page-range>625-32</page-range>
            <pub-id pub-id-type="pmid">5568616</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MUSTARDE</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>EPICANTHUS AND TELECANTHUS.</article-title>
            <source>Br J Plast Surg</source>
            <year>1963</year>
            <month>Oct</month>
            <volume>16</volume>
            <fpage>346</fpage>
            <page-range>346-56</page-range>
            <pub-id pub-id-type="pmid">14077771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>JOHNSON</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Operations for epicanthus and blepharophimosis; an evaluation and a method for shortening the medial canthal ligament.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1956</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>1</issue>
            <fpage>71</fpage>
            <page-range>71-9</page-range>
            <pub-id pub-id-type="pmid">13275546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lewis</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Arons</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Blocker</surname>
                <given-names>TG</given-names>
              </name>
            </person-group>
            <article-title>The congenital eyelid syndrome.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>1967</year>
            <month>Mar</month>
            <volume>39</volume>
            <issue>3</issue>
            <fpage>271</fpage>
            <page-range>271-7</page-range>
            <pub-id pub-id-type="pmid">5336149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MUSTARDE</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>EPICANTHUS AND TELECANTHUS.</article-title>
            <source>Int Ophthalmol Clin</source>
            <year>1964</year>
            <month>Jun</month>
            <volume>4</volume>
            <fpage>359</fpage>
            <page-range>359-76</page-range>
            <pub-id pub-id-type="pmid">14199224</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garden</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Blepharophimosis, ptosis, epicanthus inversus and lacrimal stenosis.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1969</year>
            <month>Jan</month>
            <volume>67</volume>
            <issue>1</issue>
            <fpage>153</fpage>
            <page-range>153-4</page-range>
            <pub-id pub-id-type="pmid">5782860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Kyung</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>SY</given-names>
              </name>
            </person-group>
            <article-title>The factors influencing visual development in blepharophimosis-ptosis-epicanthus inversus syndrome.</article-title>
            <source>J Pediatr Ophthalmol Strabismus</source>
            <year>2006</year>
            <season>Sep-Oct</season>
            <volume>43</volume>
            <issue>5</issue>
            <fpage>285</fpage>
            <page-range>285-8</page-range>
            <pub-id pub-id-type="pmid">17022162</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Landau Prat</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nguyen</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Strong</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Katowitz</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Katowitz</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>"Blepharophimosis-plus" syndromes: Frequency of systemic genetic disorders that also include blepharophimosis.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>49</volume>
            <issue>5</issue>
            <fpage>448</fpage>
            <page-range>448-453</page-range>
            <pub-id pub-id-type="pmid">33882191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Valetto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baldinotti</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Azzar&#x000e0;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cambi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Toschi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Giacomina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gatti</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Gana</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Caligo</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bertelloni</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Blepharophimosis, Ptosis, Epicanthus Inversus Syndrome: New Report with a 197-kb Deletion Upstream of <italic>FOXL2</italic> and Review of the Literature.</article-title>
            <source>Mol Syndromol</source>
            <year>2019</year>
            <month>May</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>147</fpage>
            <page-range>147-153</page-range>
            <pub-id pub-id-type="pmid">31191203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhuang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>[Clinical and genetic analysis of a patient with 10q26.3 microdeletion in conjunct with 18q22.3q23 microduplication].</article-title>
            <source>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</source>
            <year>2022</year>
            <month>Dec</month>
            <day>10</day>
            <volume>39</volume>
            <issue>12</issue>
            <fpage>1415</fpage>
            <page-range>1415-1418</page-range>
            <pub-id pub-id-type="pmid">36453971</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Selected Genetic Factors Associated with Primary Ovarian Insufficiency.</article-title>
            <source>Int J Mol Sci</source>
            <year>2023</year>
            <month>Feb</month>
            <day>23</day>
            <volume>24</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">36901862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zeng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>[Genetic testing and prenatal diagnosis for a family with 10q22.3q23.2 microdeletion].</article-title>
            <source>Zhonghua Yi Xue Yi Chuan Xue Za Zhi</source>
            <year>2021</year>
            <month>Aug</month>
            <day>10</day>
            <volume>38</volume>
            <issue>8</issue>
            <fpage>768</fpage>
            <page-range>768-770</page-range>
            <pub-id pub-id-type="pmid">34365621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Tao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Xie</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Intragenic and extragenic disruptions of FOXL2 mapped by whole genome low-coverage sequencing in two BPES families with chromosome reciprocal translocation.</article-title>
            <source>Genomics</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>104</volume>
            <issue>3</issue>
            <fpage>170</fpage>
            <page-range>170-6</page-range>
            <pub-id pub-id-type="pmid">25086333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huhtaniemi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hovatta</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>La Marca</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Livera</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Monniaux</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Persani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Heddar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jarzabek</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Laisk-Podar</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Salumets</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tapanainen</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Veitia</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Visser</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Wieacker</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wolczynski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Misrahi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian Insufficiency.</article-title>
            <source>Trends Endocrinol Metab</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>29</volume>
            <issue>6</issue>
            <fpage>400</fpage>
            <page-range>400-419</page-range>
            <pub-id pub-id-type="pmid">29706485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karacao&#x0011f;lan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ercan</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Bozdogan</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>One-stage repair of blepharophimosis: a new method.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>1994</year>
            <month>Jun</month>
            <volume>93</volume>
            <issue>7</issue>
            <fpage>1406</fpage>
            <page-range>1406-9</page-range>
            <pub-id pub-id-type="pmid">8208806</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhattacharjee</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bhattacharjee</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kuri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>ZT</given-names>
              </name>
              <name>
                <surname>Deori</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Single stage surgery for Blepharophimosis syndrome.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2012</year>
            <season>May-Jun</season>
            <volume>60</volume>
            <issue>3</issue>
            <fpage>195</fpage>
            <page-range>195-201</page-range>
            <pub-id pub-id-type="pmid">22569380</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Shao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>One-stage correction of blepharophimosis-ptosis-epicanthus inversus syndrome using a frontalis muscle transfer technique.</article-title>
            <source>J Plast Surg Hand Surg</source>
            <year>2014</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>74</fpage>
            <page-range>74-9</page-range>
            <pub-id pub-id-type="pmid">23968369</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wu</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tsai</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>JZ</given-names>
              </name>
            </person-group>
            <article-title>One-stage correction for blepharophimosis syndrome.</article-title>
            <source>Eye (Lond)</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>22</volume>
            <issue>3</issue>
            <fpage>380</fpage>
            <page-range>380-8</page-range>
            <pub-id pub-id-type="pmid">17115018</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mastellari</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>La Marca</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Genetic conditions impairing female fertility.</article-title>
            <source>Panminerva Med</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>260</fpage>
            <page-range>260-267</page-range>
            <pub-id pub-id-type="pmid">33185415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonus</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Pothast</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lamb</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Feinberg</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Bernardi</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Planned oocyte cryopreservation in women with blepharophimosis-ptosis-epicanthus inversus syndrome: a case series.</article-title>
            <source>F S Rep</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>332</fpage>
            <page-range>332-337</page-range>
            <pub-id pub-id-type="pmid">34553160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meng</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Qin</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jiao</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Ovarian Reserve and ART Outcomes in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Patients With <italic>FOXL2</italic> Mutations.</article-title>
            <source>Front Endocrinol (Lausanne)</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>829153</fpage>
            <pub-id pub-id-type="pmid">35574016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baber</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Panay</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fenton</surname>
                <given-names>A</given-names>
              </name>
              <collab>IMS Writing Group</collab>
            </person-group>
            <article-title>2016 IMS Recommendations on women's midlife health and menopause hormone therapy.</article-title>
            <source>Climacteric</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>19</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <page-range>109-50</page-range>
            <pub-id pub-id-type="pmid">26872610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nelson</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Clinical practice. Primary ovarian insufficiency.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Feb</month>
            <day>05</day>
            <volume>360</volume>
            <issue>6</issue>
            <fpage>606</fpage>
            <page-range>606-14</page-range>
            <pub-id pub-id-type="pmid">19196677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rong</surname>
                <given-names>WN</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>SQ</given-names>
              </name>
              <name>
                <surname>Sheng</surname>
                <given-names>XL</given-names>
              </name>
            </person-group>
            <article-title>Identification of a novel FOXL2 mutation in a fourth-generation Chinese family with blepharophimosis-ptosis-epicanthus inversus syndrome.</article-title>
            <source>Int J Ophthalmol</source>
            <year>2021</year>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>504</fpage>
            <page-range>504-509</page-range>
            <pub-id pub-id-type="pmid">33875939</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cheng</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Yuan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title><italic>ITGB5</italic> mutation discovered in a Chinese family with blepharophimosis-ptosis-epicanthus inversus syndrome.</article-title>
            <source>Open Life Sci</source>
            <year>2021</year>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>1268</fpage>
            <page-range>1268-1277</page-range>
            <pub-id pub-id-type="pmid">34966851</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bashamboo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Eozenou</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jorgensen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bignon-Topalovic</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Siffroi</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hyon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nagy</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>S&#x000f3;lyom</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hal&#x000e1;sz</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Paye-Jaouen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rodriguez-Buritica</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bertalan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Martinerie</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rajpert-De Meyts</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Achermann</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>McElreavey</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Loss of Function of the Nuclear Receptor NR2F2, Encoding COUP-TF2, Causes Testis Development and Cardiac Defects in 46,XX Children.</article-title>
            <source>Am J Hum Genet</source>
            <year>2018</year>
            <month>Mar</month>
            <day>01</day>
            <volume>102</volume>
            <issue>3</issue>
            <fpage>487</fpage>
            <page-range>487-493</page-range>
            <pub-id pub-id-type="pmid">29478779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clayton-Smith</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Sullivan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bhaskar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Day</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Voss</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Biesecker</surname>
                <given-names>LG</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fryer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chandler</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Kerr</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Tassabehji</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lynch</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Krajewska-Walasek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McKee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sweeney</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mansour</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mohammed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Donnai</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome.</article-title>
            <source>Am J Hum Genet</source>
            <year>2011</year>
            <month>Nov</month>
            <day>11</day>
            <volume>89</volume>
            <issue>5</issue>
            <fpage>675</fpage>
            <page-range>675-81</page-range>
            <pub-id pub-id-type="pmid">22077973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baraitser</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES syndrome).</article-title>
            <source>J Med Genet</source>
            <year>1988</year>
            <month>Jan</month>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>47</fpage>
            <page-range>47-51</page-range>
            <pub-id pub-id-type="pmid">3270326</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r56">
          <label>56</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Shukla</surname>
                <given-names>UV</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>BC</given-names>
              </name>
            </person-group>
            <chapter-title>Congenital Ptosis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">33760447</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r57">
          <label>57</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Ahmed jan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Mui</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Masood</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <chapter-title>Waardenburg Syndrome</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>4</day>
            <pub-id pub-id-type="pmid">32809714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saint-Laurent</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mazeyrie</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Yart</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Edouard</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Novel therapeutic perspectives in Noonan syndrome and RASopathies.</article-title>
            <source>Eur J Pediatr</source>
            <year>2024</year>
            <month>Mar</month>
            <volume>183</volume>
            <issue>3</issue>
            <fpage>1011</fpage>
            <page-range>1011-1019</page-range>
            <pub-id pub-id-type="pmid">37863846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bains</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mutalikdesai</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Apert syndrome: craniofacial challenges and clinical implications.</article-title>
            <source>BMJ Case Rep</source>
            <year>2024</year>
            <month>Jul</month>
            <day>16</day>
            <volume>17</volume>
            <issue>7</issue>
            <pub-id pub-id-type="pmid">39013624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nuovo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Passeri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Benedetto</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Calanchini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Meldolesi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Di Giacomo</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Petruzzi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Piemontese</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Zelante</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sangiuolo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Novelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fabbri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brancati</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Characterization of endocrine features and genotype-phenotypes correlations in blepharophimosis-ptosis-epicanthus inversus syndrome type 1.</article-title>
            <source>J Endocrinol Invest</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-33</page-range>
            <pub-id pub-id-type="pmid">26100530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amer</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Abdellah</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>NHF</given-names>
              </name>
              <name>
                <surname>Mounir</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Surgical outcome of epicanthus and telecanthus correction by C-U medial canthoplasty with lateral canthoplasty in treatment of Blepharophimosis syndrome.</article-title>
            <source>BMC Ophthalmol</source>
            <year>2022</year>
            <month>May</month>
            <day>19</day>
            <volume>22</volume>
            <issue>1</issue>
            <fpage>226</fpage>
            <pub-id pub-id-type="pmid">35590300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sa</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>KI</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YD</given-names>
              </name>
            </person-group>
            <article-title>A new method of medial epicanthoplasty for patients with blepharophimosis-ptosis-epicanthus inversus syndrome.</article-title>
            <source>Ophthalmology</source>
            <year>2012</year>
            <month>Nov</month>
            <volume>119</volume>
            <issue>11</issue>
            <fpage>2402</fpage>
            <page-range>2402-7</page-range>
            <pub-id pub-id-type="pmid">22835816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Savino</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mandar&#x000e0;</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Calandriello</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Dickmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Petroni</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>A Modified One-Stage Early Correction of Blepharophimosis Syndrome Using Tutopatch Slings.</article-title>
            <source>Orbit</source>
            <year>2015</year>
            <volume>34</volume>
            <issue>4</issue>
            <fpage>186</fpage>
            <page-range>186-91</page-range>
            <pub-id pub-id-type="pmid">26043072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-151524.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fokstuen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Antonarakis</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Blouin</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>FOXL2-mutations in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES); challenges for genetic counseling in female patients.</article-title>
            <source>Am J Med Genet A</source>
            <year>2003</year>
            <month>Mar</month>
            <day>01</day>
            <volume>117A</volume>
            <issue>2</issue>
            <fpage>143</fpage>
            <page-range>143-6</page-range>
            <pub-id pub-id-type="pmid">12567411</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
